Piscataway, NJ, United States of America

Yuan-Ching P Chiang


Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 226(Granted Patents)


Location History:

  • Piscataway, NJ (US) (1989 - 1992)
  • East Lyme, CT (US) (1999)
  • Scotch Plains, NJ (US) (1993 - 2000)

Company Filing History:


Years Active: 1989-2000

Loading Chart...
13 patents (USPTO):

Title: Innovations of Yuan-Ching P Chiang

Introduction

Yuan-Ching P Chiang is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurokinin receptors. With a total of 13 patents to his name, his work has implications for treating various inflammatory diseases and conditions.

Latest Patents

Among his latest patents, one notable invention is the "Spiro-substituted azacycles as neurokinin antagonists." This patent discloses spiro-substituted azacycles that serve as tachykinin receptor antagonists, which are useful in treating inflammatory diseases, pain, migraine, and asthma. Another significant patent is the "Phenyl spiroethercycloalkyl tachykinin receptor antagonists." This invention focuses on novel compounds that are also tachykinin receptor antagonists, with applications in treating similar disorders.

Career Highlights

Yuan-Ching P Chiang is currently associated with Merck & Company, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that address critical health issues.

Collaborations

He has collaborated with notable colleagues, including Michael N Chang and Shu S Yang, who contribute to the research and development of his innovative compounds.

Conclusion

Yuan-Ching P Chiang's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…